Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cranberry pills tested for bathroom breaks

NCT ID NCT07393126

Symptom relief Sponsor: Indena S.p.A Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a daily cranberry phospholipid supplement can reduce how often healthy Japanese adults need to urinate during the day. Over eight weeks, 76 participants will take either the supplement or a placebo and answer questionnaires about their bladder symptoms and quality of life. The goal is to see if the supplement eases urinary frequency without medical treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cranberry phospholipids
What this could lead to
If it works, this could point toward a natural supplement to ease frequent urination in healthy adults.
What could go wrong
This is a small, early-stage trial with only 76 participants. The effect may be small or no better than placebo, and results may not apply to other groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Japanese * Men or women * Adults * Healthy individuals * Individuals with positive urine leukocytes at baseline * Individuals whose score of urinary urgency of overactive bladder symptom score (OABSS) is less than two or total score of OABSS is less than three at baseline * Individuals whose "frequent urination during the daytime hours" of "symptom bother" of OAB-q is relatively high at baseline Exclusion Criteria: * Individuals undergoing medical treatment or having a medical history of malignant tumor, heart failure, or myocardial infarction * Individuals carrying a pacemaker or an implantable cardioverter defibrillator * Individuals undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases * Individuals who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage as part of their daily diet * Individuals currently regularly taking medications (including herbal medicines) and supplements * Individuals who are allergic to medicines and/or the test-product-related products in this trial * Individuals with urinary pain * Individuals undergoing treatment, have had treatment within two months, or need the treatment for diseases related to urination, e.g. benign prostatic hypertrophy, prostatitis, prostate cancer, overactive bladder, hypoactive bladder, cystitis, interstitial cystitis, bladder cancer, bladder stones, urethritis, urethral stricture, neurological disease, polyuria, and nocturnal polyuria * Individuals have overactive bladder symptom (individuals who urinate eight times or more per day, and have urinary urgency at least once a week) * Individuals wake up twice or more to urinate at bedtime * Individuals are pregnant, breast-feeding, and planning to become pregnant * Individuals have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial * Individuals are judged as ineligible to participate in the trial by the physician

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy japanese are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy japanese

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Medical Corporation Seishinkai, Takara Clinic

    RECRUITING

    Shinagawa-Ku, Tokyo, 141-0022, Japan

  • Nerima Medical Association Minami-machi Clinic

    RECRUITING

    Nerima-ku, Tokyo, 176-0002, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.